be_ixf;ym_202411 d_24; ct_50
NASDAQ:GOOGL charts & data provided by TradingView

Latest Insights on GOOGL

Don’t Drink the Tesla Kool-Aid — Here’s a Smarter Buy
by Anthony Planas February 7, 2020 American Investor Today, Stocks
Tesla shares surged to nearly $1,000 on Tuesday. But the carmaker’s rally is a sign of euphoria for growth stocks. And that’s bad news for future returns. Anthony Planas tells you why you need to park your money in a forgotten sector.
david and goliath amazon Amazon’s $1 Trillion Playbook: How to Buy the Next Market Disruptor
by Charles Mizrahi February 6, 2020 American Investor Today, Trading Strategies
Today, Amazon and Netflix are known as industry disruptors. But in their early days, they were considered underdogs going up against giant brick-and-mortar retail chains. Today, Charles Mizrahi uncovers the one secret that underpins “underdogs” such as Netflix and Amazon.
If you don’t think the Wuhan coronavirus outbreak will impact the U.S. economy, I’ve got some bad news for you. The Chinese Time Bomb; Tesla Tendies Time
by Joseph Hargett February 4, 2020 Great Stuff
The Ticking Chinese Time Bomb Sorry to ruin your bull market party, but there’s an issue we need to discuss … like, right now. I’m talking about the Wuhan coronavirus and the U.S.-China “phase 1” trade deal. Here’s the thing: More than 20,000 Chinese are infected with the Wuhan virus, with some 427 dead. Tens […]
Wuhan virus is pushing internet stocks higher The Wuhan Virus Is Pushing These Stocks Higher
by Ted Bauman February 4, 2020 Big Picture. Big Profits., Global Economy, Investment Opportunities, News
[4-minute read] Don’t miss out on one of the best opportunities to ever come from this massive economy.
abbvie stock Profit From AbbVie’s Struggles Today
by Chad Shoop February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

Share This